Clinical study of Jianpi Sanjie Recipe in prevention and treatment of drug resistance of colorectal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003793

Enrollment

Unknown

Registered

2020-08-28

Start date

2020-09-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

experimental group:Jianpi Sanjie Recipe + chemotherapy

control group:chemotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) According to the diagnostic criteria of spleen deficiency syndrome, stage III and stage IV colorectal cancer were met; (2) Patients who received chemotherapy; (3) Aged >= 18 years, sex is not limited; (4) For patients who can receive TCM or western medicine treatment for a long time (more than 3 months), ECoG <= 2; (5) Patients voluntarily accepted follow-up and signed informed consent; (6) The follow-up and clinical data were complete.

Exclusion criteria

Exclusion criteria: (1) Patients in pregnancy, lactation or planned pregnancy; (2) Those who are allergic to the drugs used in this study or their ingredients; (3) Patients with severe heart, brain, liver, kidney disease or mental illness; (4) Major surgery was performed within 6 weeks.

Design outcomes

Primary

Measure	Time frame
DFS;QLQ-CR38;MDR1mRNA;PFS;OS;TTP;	—

Countries

China

Contacts

Public ContactLin Jing

Shanghai Hospital of traditional Chinese Medicine

jinglin1004@163.com+86 13120962726

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026